Small Molecule Therapeutics for Schizophrenia, 2015 Topics in Medicinal Chemistry Series, Vol. 13
Coordonnateurs : Celanire Sylvain, Poli Sonia
Antipsychotics and the Dopamine–Serotonin Connection.- GLYT1 Inhibitors: From Hits to Clinical Candidates.- Metabotropic Glutamate Receptor 2 Activators.- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders.- Muscarinic Acetylcholine Receptor Activators.- Nicotinic Acetylcholine Receptor Modulators.-The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
Date de parution : 08-2016
Ouvrage de 323 p.
15.5x23.5 cm
Date de parution : 10-2014
Ouvrage de 323 p.
15.5x23.5 cm